Pharmaceuticals & Biotechnology
Caplin Point Laboratories Limited
ISIN: INE475E01026 · Data as of Apr 2026
Share: WhatsApp X
Active Funds Holding
6
vs Last Month
0 funds
Total Value
₹221.67 Cr
Avg Weight
1.22%
New Entries
0
Exits
0
Top Holder
UTI Healthcare Fund - Direct Plan - Growth Option 2.17%
ℹ️ Index funds and ETFs are excluded from this analysis. They passively track an index and hold stocks mechanically — not because of a fund manager's conviction. Only actively managed funds reflect genuine fund manager decisions.
📋 What Changed This Month

Caplin Point Laboratories Limited is currently held by 6 active mutual funds (excluding ETFs and Index funds) with a total exposure of ₹221.67 Cr. UTI Healthcare Fund - Direct Plan - Growth Option has the highest allocation at 2.17%, followed by UTI Multi Cap Fund - Direct Plan - Growth Option at 1.37%. ↓ Scroll down for full fund list and monthly changes.

Trend
Active Fund Count — Last 3 Months
Feb
Mar
Apr
By Category
Fund Category Breakdown
CategoryFundsAvg WeightDistribution
Equity 2 1.48%
Multi Cap 1 1.37%
Aggressive Hybrid 1 0.76%
Mid Cap 1 0.93%
Small Cap 1 1.32%
All Holdings
All 6 Active Funds Holding Caplin Point Laboratories Limited
Filter:
Fund ↕ Category ↕ Weight ↕ Value ↕ Change ↕
UTI Healthcare Fund - Direct Plan - Growth Option
UTI Mutual Fund
Equity 2.17% ₹24.81 Cr +0.1%
UTI Multi Cap Fund - Direct Plan - Growth Option
UTI Mutual Fund
Multi Cap 1.37% ₹26.49 Cr
UTI Small Cap Fund - Direct Plan - Growth Option
UTI Mutual Fund
Small Cap 1.32% ₹64.40 Cr -0.04%
UTI Large & Mid Cap Fund - Direct Plan - Growth Option
UTI Mutual Fund
Mid Cap 0.93% ₹54.92 Cr +0.01%
ITI Pharma and Healthcare Fund - Direct Plan - Growth Option
ITI Mutual Fund
Equity 0.78% ₹1.79 Cr +0.04%
UTI Aggressive Hybrid Fund -Direct Plan - Growth
UTI Mutual Fund
Aggressive Hybrid 0.76% ₹49.27 Cr +0.05%